Incyte sec filings
WebApr 13, 2024 · The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Maria E. Pasquale sold 60,024 shares of Incyte stock in a transaction that occurred on Monday, January 30th. The stock was sold at an average price of $84.74, for a total value of $5,086,433.76. WebApr 13, 2024 · The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Incyte news, EVP Vijay K. Iyengar sold 7,000 shares of the firm ...
Incyte sec filings
Did you know?
WebOct 4, 2024 · INCY SEC Filings - Incyte Corporation - Annual Report, Proxy Statement, Prospectus. ... SEC Filings All companies that sell securities in the United States must … WebApr 5, 2024 · INCY traded up $1.14 on Wednesday, hitting $73.79. 266,480 shares of the company's stock were exchanged, compared to its average volume of 1,653,264. The company has a current ratio of 3.54, a quick ratio of 3.50 and a debt-to-equity ratio of 0.01. The stock has a fifty day moving average of $77.16 and a two-hundred day moving …
WebJan 9, 2024 · WILMINGTON, D.E. & KENILWORTH, N.J. – Incyte Corporation (Nasdaq:INCY) and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the decision to advance the clinical development program investigating the combination of epacadostat, Incyte’s investigational oral selective IDO1 inhibitor, with …
WebFeb 7, 2024 · Incyte Corp (INCY) SEC Filing 8-K Material Event for the period ending Tuesday, February 7, 2024. HOME; LOGIN; PREMIUM; FREE TRIAL; SEC FILINGS; STOCK SCREENERS. WebSEC Filings Incyte Corp (INCY) 10-K Annual Report Tue Feb 07 2024 10-Q Quarterly Report May 2024 10-Q Quarterly Report November 2024 10-Q Quarterly Report August 2024 10-Q …
WebApr 9, 2024 · The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Incyte news, EVP …
WebFeb 9, 2024 · Incyte Corp (INCY) SEC Filing 10-K Annual report for the fiscal year ending Thursday, December 31, 2024. Home. SEC Filings. Incyte Corp (INCY) 10-K Annual Report Tue Feb 09 2024 ... Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats. Last10K.com Member Feature. Export Annual and Quarterly Reports to Adobe … greencore srlWebSep 27, 2024 · The companies will share development costs associated with global and U.S. -specific trials for all agreed upon trials at a rate of 55% ( Incyte) and 45% (Syndax), with Incyte responsible for 100% of future development costs for trials that are specific to ex- … greencore springfield meadowsWebApr 12, 2024 · Ballentine Partners LLC acquired a new position in shares of Incyte Co. ( NASDAQ:INCY - Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 2,609 shares of the biopharmaceutical company's stock, valued at approximately $210,000. 3 S&P 500 … flowtron leaf shredder partsWebApr 6, 2024 · INCY Incyte CorporationSEC Filings. $75.51 1.73 ( +2.34%) 4:00 PM 04/06/23. NASDAQ $USD Post-Market: $76.42 +0.91 (+1.21%) 7:34 PM. Summary. Ratings. … greencore structureWebLilly and Incyte Announce Collaboration for Development and Commercialization of Oral Anti-Inflammatory and Autoimmune Therapies. December 21, 2009 ... Incyte's dependence on its relationship with its collaboration partners, and other risks detailed from time to time in Incyte's filings with the Securities and Exchange Commission, including its ... flowtron light bulb dimWebApr 11, 2024 · Exchange Traded Concepts LLC decreased its position in Incyte Co. (NASDAQ:INCY - Get Rating) by 7.5% during the 4th quarter, according to the company in … greencore sushi crosbyWebApr 15, 2024 · Sumitomo Mitsui Trust Holdings Inc. owned approximately 0.34% of Incyte worth $59,867,000 as of its most recent filing with the Securities and Exchange Commission (SEC). greencore spec save